脂蛋白超敏C反应蛋白联合检测在2型糖尿病肾病患者中价值评价.docVIP

脂蛋白超敏C反应蛋白联合检测在2型糖尿病肾病患者中价值评价 　　[摘要] 目的 研究和评价针对2型糖尿病肾病患者给予脂蛋白（a）、超敏C反应蛋白联合检测的临床价值。方法 选取2014年5月―2016年2月来该院治疗的2型糖尿病肾病患者60例作为此次报告的研究对象，设为试验组。另外选取2015年6月―2016年6月该院收治的单纯糖尿病患者60例作为空白对照，设为对照组。结果 结果显示，经过血液的自动生化分析仪检测可知，试验组血液中的脂蛋白（a）、超敏C反应蛋白的含量水平明显高于对照组，差异有统计学意义（P0.05）。两组血液样本的检测结果可知，脂蛋白（a）、超敏C反应蛋白联合检测后，患者的阳性率高达86.9%。结论 脂蛋白（a）、超敏C反应蛋白作为衡量2型糖尿病肾病的指标，临床在患者早期及时的进行该指标的检测，可以有效的预测患者的疾病发展状况，保障患者的治疗效果。 　　[关键词] 2型糖尿病肾病??脂蛋白（a）；超敏C反应蛋白；临床价值 　　[中图分类号] R587 [文献标识码] A [文章编号] 1672-4062（2016）10（b）-0123-02 　　[Abstract] Objective To study and evaluate the clinical value of combined detection of serum lipoprotein and high sensitive C reactive protein in patients with type 2 diabetic nephropathy. Methods 2 cases of type 60 diabetic nephropathy patients treated in our hospital from May 2014 to February 2016 were selected as the research object of this report. In addition， 60 cases of patients with simple diabetes in our hospital from June 2015 to June 2016 were selected as blank control group， and the control group was established as the control group. Results Results showed that， after blood was detected by automatic biochemistry analyzer shows that， the experimental group in the blood serum lipoprotein， high sensitive C reactive protein level was significantly higher than that of control group， visible differences exist（P 0.05）. The blood samples of the two groups showed that the positive rate of serum lipoprotein and high sensitive C reactive protein was 86.9%. Conclusion Serum lipoprotein and high sensitivity C-reactive protein as a measure of type 2 diabetic nephropathy， clinical in patients with early-stage timely were detection of the index， can effectively predict a patients disease development and to protect the patients treatment effect. 　　[Key words] Type 2 diabetic nephropathy； Serum lipoprotein； High sensitive C reactive protein； Clinical value 　　2型糖尿病是一种自然免疫和慢性炎症疾病，常伴有胰岛素抵抗，与肥胖、高血压和脂代谢紊乱等构成代谢综合征[1]。目前，临床主要把白蛋白尿作为诊断糖尿病肾病的金标准。随着社会的不断发展和医疗水平的逐渐提高，人们对于2型糖尿病肾病的发病机理更加的重视起来。研究发现，脂蛋